ASFX (American Scientific Resources) Additional Paid-In Capital: $26.04 Mil(As of Sep. 2011)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is American Scientific Resources Additional Paid-In Capital?

American Scientific Resources ASFX -96.67% Additional Paid-In Capital is $26.04 Mil as of Sep. 2011.


American Scientific Resources's quarterly additional paid-in capital increased from Mar. 2011 ($ Mil) to Jun. 2011 ($25.31 Mil) and increased from Jun. 2011 ($25.31 Mil) to Sep. 2011 ($26.04 Mil).

American Scientific Resources's annual additional paid-in capital increased from Dec. 2008 ($13.52 Mil) to Dec. 2009 ($18.78 Mil) and increased from Dec. 2009 ($18.78 Mil) to Dec. 2010 ($21.13 Mil).

American Scientific Resources Additional Paid-In Capital Related Terms

American Scientific Resources Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for American Scientific Resources's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

American Scientific Resources Additional Paid-In Capital Chart

American Scientific Resources Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10
Additional Paid-In Capital
Get a 7-Day Free Trial 6.13 8.48 13.52 18.78 21.13

American Scientific Resources Quarterly Data
Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.42 21.13 - 25.31 26.04

American Scientific Resources Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of $26.04 Mil mean?
American Scientific Resources (ASFX) has a Additional Paid-In Capital of $26.04 Mil as of Sep. 2011. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on American Scientific Resources and its competitors.
Is American Scientific Resources' Additional Paid-In Capital too high?
American Scientific Resources' current Additional Paid-In Capital is $26.04 Mil.
How does American Scientific Resources' Additional Paid-In Capital compare to GNID and QTXB?
American Scientific Resources' Additional Paid-In Capital of $26.04 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Medical Devices & Instruments company?
A good Additional Paid-In Capital depends on the Medical Devices & Instruments industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on American Scientific Resources and its competitors. American Scientific Resources's current Additional Paid-In Capital is $26.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is American Scientific Resources stock overvalued right now?
American Scientific Resources (ASFX) has a current Additional Paid-In Capital of $26.04 Mil. The current Additional Paid-In Capital is $26.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For American Scientific Resources (ASFX), the current Additional Paid-In Capital is $26.04 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

American Scientific Resources Business Description

Address 1112 Weston Road, Unit 278, Weston, FL, USA, 33326
American Scientific Resources Inc. is a U.S.-based medical device and consumer health products company. It develops, markets, and distributes a portfolio of health and safety products, including the Kidz-Med brand of children's thermometers and related pediatric health items, as well as other medical devices and over-the-counter health products. Its products are sold through retail drugstore chains, national medical supply distributors, direct-response infomercials, and online channels. The company generates revenue primarily through product sales to retail and wholesale customers, supplemented by direct-to-consumer sales. Its market is predominantly the United States, with some distribution through international channels. The company has historically operated as a small-cap, thinly traded public entity and has undergone various corporate changes over time.